Carmen Bozic is EVP and CMO of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 23,259 shares of VRTX, which is worth approximately $11.7 Million. The most recent transaction as insider was on Feb 17, 2022, when has been sold 3,439 shares (Common Stock) at a price of $232.51 per share, resulting in proceeds of $799,602. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.3K
0% 3M change
33.45% 12M change
Total Value Held $11.7 Million

Carmen Bozic Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2022
SELL
Payment of exercise price or tax liability
$799,602 $232.51 p/Share
3,439 Reduced 6.31%
51,065 Common Stock
Feb 10 2022
SELL
Payment of exercise price or tax liability
$579,372 $237.74 p/Share
2,437 Reduced 4.28%
54,504 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
23,988 Added 29.64%
56,941 Common Stock
May 28 2021
SELL
Payment of exercise price or tax liability
$65,322 $210.04 p/Share
311 Reduced 0.93%
32,953 Common Stock
Feb 24 2021
SELL
Payment of exercise price or tax liability
$67,664 $217.57 p/Share
311 Reduced 0.93%
33,264 Common Stock
Feb 10 2021
SELL
Payment of exercise price or tax liability
$506,917 $214.16 p/Share
2,367 Reduced 6.59%
33,575 Common Stock
Feb 03 2021
BUY
Grant, award, or other acquisition
-
21,951 Added 37.92%
35,942 Common Stock
CB

Carmen Bozic

EVP and CMO
Boston, MA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX